Advertisement

Index by author

August 01, 2011; Volume 39,Issue 8

  1. Miners, John O.

    1. Effects of Ketamine on Human UDP-Glucuronosyltransferases In Vitro Predict Potential Drug-Drug Interactions Arising from Ketamine Inhibition of Codeine and Morphine Glucuronidation
      Verawan Uchaipichat, Pritsana Raungrut, Nuy Chau, Benjamas Janchawee, Allan M. Evans and John O. Miners
      Drug Metabolism and Disposition August 2011, 39 (8) 1324-1328; DOI: https://doi.org/10.1124/dmd.111.039727

  2. Morrison, Glenn

    1. A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry
      Richard A. Graham, Bert L. Lum, Glenn Morrison, Ilsung Chang, Karin Jorga, Brian Dean, Young G. Shin, Qin Yue, Teresa Mulder, Vikram Malhi, Minli Xie, Jennifer A. Low and Cornelis E. C. A. Hop
      Drug Metabolism and Disposition August 2011, 39 (8) 1460-1467; DOI: https://doi.org/10.1124/dmd.111.039339

  3. Mount, Natalie M.

    1. Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist
      Peter J. Bungay, Sarah Tweedy, David C. Howe, Karl R. Gibson, Hannah M. Jones and Natalie M. Mount
      Drug Metabolism and Disposition August 2011, 39 (8) 1396-1405; DOI: https://doi.org/10.1124/dmd.110.037234

  4. Mulder, Teresa

    1. A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry
      Richard A. Graham, Bert L. Lum, Glenn Morrison, Ilsung Chang, Karin Jorga, Brian Dean, Young G. Shin, Qin Yue, Teresa Mulder, Vikram Malhi, Minli Xie, Jennifer A. Low and Cornelis E. C. A. Hop
      Drug Metabolism and Disposition August 2011, 39 (8) 1460-1467; DOI: https://doi.org/10.1124/dmd.111.039339

  5. Nakajima, Miki

    1. Development of a Highly Sensitive Cytotoxicity Assay System for CYP3A4-Mediated Metabolic Activation
      Hiroko Hosomi, Tatsuki Fukami, Atsushi Iwamura, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2011, 39 (8) 1388-1395; DOI: https://doi.org/10.1124/dmd.110.037077
    2. Human Paraoxonase 1 Is the Enzyme Responsible for Pilocarpine Hydrolysis
      Tomomi Hioki, Tatsuki Fukami, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2011, 39 (8) 1345-1352; DOI: https://doi.org/10.1124/dmd.111.038141

  6. Naud, Judith

    1. Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats
      Judith Naud, Josée Michaud, Stéphanie Beauchemin, Marie-Josée Hébert, Michel Roger, Stéphane Lefrancois, Francois A. Leblond and Vincent Pichette
      Drug Metabolism and Disposition August 2011, 39 (8) 1363-1369; DOI: https://doi.org/10.1124/dmd.111.039115

  7. Niemira, Magdalena

    1. The Imidazoacridinone Antitumor Drug, C-1311, Is Metabolized by Flavin Monooxygenases but Not by Cytochrome P450s
      Agnieszka Potega, Emilia Dabrowska, Magdalena Niemira, Agata Kot-Wasik, Sebastien Ronseaux, Colin J. Henderson, C. Roland Wolf and Zofia Mazerska
      Drug Metabolism and Disposition August 2011, 39 (8) 1423-1432; DOI: https://doi.org/10.1124/dmd.111.038984

  8. Noh, Kyoung

    1. Farnesoid X Receptor Activation by Chenodeoxycholic Acid Induces Detoxifying Enzymes through AMP-Activated Protein Kinase and Extracellular Signal-Regulated Kinase 1/2-Mediated Phosphorylation of CCAAT/Enhancer Binding Protein β
      Kyoung Noh, Young Mi Kim, Young Woo Kim and Sang Geon Kim
      Drug Metabolism and Disposition August 2011, 39 (8) 1451-1459; DOI: https://doi.org/10.1124/dmd.111.038414

  9. Ogilvie, Brian W.

    1. An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes
      Andrew Parkinson, Faraz Kazmi, David B. Buckley, Phyllis Yerino, Brandy L. Paris, Jeff Holsapple, Paul Toren, Steve M. Otradovec and Brian W. Ogilvie
      Drug Metabolism and Disposition August 2011, 39 (8) 1370-1387; DOI: https://doi.org/10.1124/dmd.111.038596

  10. Otradovec, Steve M.

    1. An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes
      Andrew Parkinson, Faraz Kazmi, David B. Buckley, Phyllis Yerino, Brandy L. Paris, Jeff Holsapple, Paul Toren, Steve M. Otradovec and Brian W. Ogilvie
      Drug Metabolism and Disposition August 2011, 39 (8) 1370-1387; DOI: https://doi.org/10.1124/dmd.111.038596
« Previous (Pages : 2 3 4 5 6 7 8 9 10 ... 10) Next »
Back to top

In this issue

Advertisement